Soquelitinib inhibition of IL-2-inducible T cell kinase ameliorates lung damage in murine models of systemic sclerosis

Gonçalo Boleto, Anne Cauvet, Christophe Guignabert, Raphaël Thuillet, Mina Ottaviani, Ly Tu, Lih-Yun Hsu, James T. Rosenbaum, Richard A. Miller, Yannick Allanore · 2025

Read Soquelitinib inhibition of IL-2-inducible T cell kinase ameliorates lung damage in murine models of systemic sclerosis by Gonçalo Boleto, Anne Cauvet, Christophe Guignabert, Raphaël Thuillet, Mina Ottaviani, Ly Tu, Lih-Yun Hsu, James T. Rosenbaum, Richard A. Miller, Yannick Allanore (2025) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-12729254.txt.

Description

Goncalo Boleto and nine co-authors tested a targeted drug in mouse models of a scarring disease in a 2025 study. Systemic sclerosis stiffens skin and organs, and lung damage is its deadliest part. Overactive T cells drive the early inflammation. The drug blocks a switch inside T cells that helps turn them on.

In one model, a chemical injures the lungs and causes scarring. The drug cut immune cell inflow and eased tissue damage, mainly by calming two T cell branches, though stored collagen did not change. In a second model that also develops high lung blood pressure, the drug improved health scores, tissue scores, and the pressure problem. Signals from one T cell branch fell in the lungs. The authors read the results as support for testing this drug class in the human disease.

Catalog record

CREATORGonçalo Boleto, Anne Cauvet, Christophe Guignabert, Raphaël Thuillet, Mina Ottaviani, Ly Tu, Lih-Yun Hsu, James T. Rosenbaum, Richard A. Miller, Yannick Allanore
YEAR2025
COLLECTIONPAPERS
FORMATTXT
FILE SIZE47 KB
VERSION1.0
LICENSECC BY 4.0
RIGHTSCC BY
SOURCEEurope PMC

Source: https://europepmc.org/articles/PMC12729254

Browse the full library · About the Tower of Babel